← Open Payments lookup

AMY STEWART: Open Payments

NPI 1568992766 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$220,769 in 503 payments from 25 companies in 2025. Trend: 2023 $70,555 · 2024 $176,813 · 2025 $220,769

Speaker / faculty: $122,894Consulting: $46,924Travel & lodging: $39,301Food & beverage: $11,649
CompanyPaymentsAmount
Janssen Biotech, Inc.143$102,395
Lilly USA, LLC81$39,410
PFIZER INC.50$24,420
Takeda Pharmaceuticals U.S.A., Inc.45$22,924
Phathom Pharmaceuticals, Inc.33$12,072
Exact Sciences Corporation12$5,573
Eli Lilly and Company4$2,877
Salix Pharmaceuticals, a division of Bausch Health US, LLC18$2,381
ABBVIE INC.28$1,521
Celltrion USA Inc.9$1,506

Products named: TREMFYA, OMVOH, VELSIPITY, ENTYVIO, VOQUEZNA, DUPIXENT, Cologuard Collection Kit, STELARA.

Industry payments across DC — which companies pay providers there.